Abstract
Aggregation of amyloid-β (Aβ)within the extracellular space of the brain into soluble and insoluble forms is central to the pathogenesis of Alzheimer’s disease. Aβ is produced in neurons by cleavage of the amyloid precursor protein (APP) subsequent to release into the brain interstitial fluid (ISF). While a substantial amount is known about APP processing, the mechanisms that regulateAβ release and thatmodulate soluble ISFAβ levels are less clear. Several studies have suggested that postsynaptic receptor activation can alter APP processing. In vitro studies have demonstrated that synaptic activity can modulate Aβ levels in themedia of cultured neurons as well. We used in vivo microdialysis to assess ISF Aβ levels in awake, behaving mice while altering hippocampal synaptic activity both pharmacologically and electrically. Electrical stimulation increased neuronal activity and rapidly increased ISF Aβ levels. In contrast, when hippocampal synaptic activity was inhibited with agents such as TTX and tetanus toxin, ISF Aβ levels were significantly reduced within hours of treatment. Using acute brain slices, we demonstrate that synaptic vesicle cycling alone, in the absence of presynaptic or postsynaptic depolarization, drives the release ofAβ fromneurons. BecauseAβ is not localizedwithin synaptic vesicles, it is likely that an event closely associated with vesicle fusion and exocytosis is the key link between synaptic transmission and Aβ release.We propose that synaptic vesicle membrane endocytosis results in more APP endocytosis, thereby increasing Aβ generation and subsequent Aβ release into the extracellular space. These data have important implications for understanding the relationship between synaptic activity and Aβ levels. This relationship will likely also inform our understanding of the pathogenesis and treatment of Alzheimer’s disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beach TG, Kuo YM, Schwab C, Walker DG, Roher AE (2001) Reduction of cortical amyloid beta levels in guinea pig brain after systemic administration of physostigmine. Neurosci Lett 310:21–24.
Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, Mintun MA (2005) Molecular, structural, and functional characterization of Alzheimer’s disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25:7709–7717.
Caccamo A, Oddo S, Billings LM, Green KN, Martinez-Coria H, Fisher A, LaFerla FM (2006) M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 49:671–682.
Cirrito JR, May PC, O’Dell MA, Taylor JW, Parsadanian M, Cramer JW, Audia JE, Nissen JS, Bales KR, Paul SM, DeMattos RB, Holtzman DM (2003) In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life. J Neurosci 23:8844–8853.
Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, Schoepp DD, Paul SM, Mennerick S, Holtzman DM (2005) Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48:913–922.
Gouras GK, Relkin NR, Sweeney D, Munoz DG, Mackenzie IR, Gandy S (1997) Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques. Ann Neurol 41:402–404.
Gusnard DA, Raichle ME, Raichle ME (2001) Searching for a baseline: functional imaging and the resting human brain. Nature Rev Neurosci 2:685–694.
Hartley DM, Walsh DM, Ye CP, Diehl T, Vasquez S, Vassilev PM, Teplow DB, Selkoe DJ (1999) Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19:8876–8884.
Ikin AF, Annaert WG, Takei K, De Camilli P, Jahn R, Greengard P, Buxbaum JD (1996) Alzheimer amyloid protein precursor is localized in nerve terminal preparations to Rab5-containing vesicular organelles distinct from those implicated in the synaptic vesicle pathway. J Biol Chem 271:31783–31786.
Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, Sisodia S, Malinow R (2003) APP Processing and Synaptic Function. Neuron 37:925–937.
Koo EH, Squazzo SL (1994) Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem 269:17386–17389.
Lesne S, Ali C, Gabriel C, Croci N, MacKenzie ET, Glabe CG, Plotkine M, Marchand-Verrecchia C, Vivien D, Buisson A (2005) NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production. J Neurosci 25:9367–9377.
Mackenzie IR, Miller LA (1994) Senile plaques in temporal lobe epilepsy. Acta Neuropathol (Berl) 87:504–510.
Marquez-Sterling NR, Lo AC, Sisodia SS, Koo EH (1997) Trafficking of cell-surface beta-amyloid precursor protein: evidence that a sorting intermediate participates in synaptic vesicle recycling. J Neurosci 17:140–151.
Newton AJ, Kirchhausen T, Murthy VN (2006) Inhibition of dynamin completely blocks compensatory synaptic vesicle endocytosis. Proc Natl Acad Sci USA 103:17955–17960.
Nitsch RM, Deng M, Tennis M, Schoenfeld D, Growdon JH (2000) The selective muscarinic M1 agonist AF102B decreases levels of total Abeta in cerebrospinal fluid of patients with Alzheimer’s disease. Ann Neurol 48:913–918.
Peraus GC, Masters CL, Beyreuther K (1997) Late compartments of amyloid precursor protein transport in SY5Y cells are involved in beta-amyloid secretion. J Neurosci 17:7714–7724.
Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL (2001) A default mode of brain function. Proc Natl Acad Sci USA 98:676–682.
Sisodia SS (1992) Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad Sci USA 89:6075–6079.
Sloviter RS, Dichter MA, Rachinsky TL, Dean E, Goodman JH, Sollas AL, Martin DL (1996) Basal expression and induction of glutamate decarboxylase and GABA in excitatory granule cells of the rat and monkey hippocampal dentate gyrus. J Comp Neurol 373:593–618.
Townsend M, Shankar GM, Mehta T, Walsh DM, Selkoe DJ (2006) Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J Physiol 572:477–492.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Cirrito, J., Stewart, F., Mennerick, S., Holtzman, D. (2008). Synaptic Transmission Dynamically Modulates Interstitial Fluid Amyloid-β Levels. In: Selkoe, D., Triller, A., Christen, Y. (eds) Synaptic Plasticity and the Mechanism of Alzheimer's Disease. Research and Perspectives in Alzheimer's Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-76330-7_10
Download citation
DOI: https://doi.org/10.1007/978-3-540-76330-7_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-76329-1
Online ISBN: 978-3-540-76330-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)